The in vitro diagnostics global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
In Vitro Diagnostics Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The insurance (providers, brokers and re-insurers) market size has grown strongly in recent years. It will grow from $8277.04 billion in 2023 to $8898.43 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to risk management needs, regulatory requirements, population growth, catastrophic events.
The insurance (providers, brokers and re-insurers) market size is expected to see strong growth in the next few years. It will grow to $11853.99 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to emerging risks, digital transformation, demographic changes, sustainable and esg focus, globalization and trade:. Major trends in the forecast period include usage-based insurance (ubi), insurtech innovation, parametric insurance, cyber insurance, peer-to-peer (p2p) insurance.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Scope Of In Vitro Diagnostics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
In Vitro Diagnostics Market Overview
Market Drivers –
The rising popularity of self-administered test kits is expected to propel the growth of the in vitro diagnostics market going forward. Self-administered test kits refer to medical or diagnostic kits designed for individuals to use on themselves without the need for medical professionals or trained personnel to administer the test at home. The self-administered test kits enhance accessibility by enabling individuals to perform diagnostic tests at home, offering convenience and potentially increasing demand for testing, particularly for previously undiagnosed conditions. For instance, in April 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, there was a significant increase in the use of at-home COVID-19 tests among U.S. adults aged 18 and older from the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). The use of at-home tests among respondents who reported COVID-19-like symptoms increased from 5.7% to 20.1%. Therefore, the rising popularity of self-administered test kits will drive the growth of the in vitro diagnostics market.
Market Trends –
Major companies operating in the in vitro diagnostics market are focusing in developing innovative products, such as the Cobas pulse system, to increase their profitability in the market. The Cobas pulse system is a professional blood glucose management solution with mobile digital health capabilities to improve patient care. For instance, in January 2022, Roche Diagnostics, a US-based developer of innovative products and services that address the prevention, diagnosis, monitoring, screening, and treatment of diseases, launched the Cobas pulse system. The Cobas pulse system is a portable device equipped with an automated glucose test strip reader, a camera, and a touchscreen for recording additional diagnostic data. Its user-friendly interface is designed for effortless implementation, featuring convenient functions that streamline processes, save time, and enhance workflows.
The in vitro diagnostics market covered in this report is segmented –
1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
3) By Type of Expenditure: Public, Private
4) By Product: Instruments/Equipment, Disposables
Get an inside scoop of the in vitro diagnostics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp
Regional Insights –
North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Key Companies –
Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.
Table of Contents
1. Executive Summary
2. In Vitro Diagnostics Market Report Structure
3. In Vitro Diagnostics Market Trends And Strategies
4. In Vitro Diagnostics Market – Macro Economic Scenario
5. In Vitro Diagnostics Market Size And Growth
…..
27. In Vitro Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
